This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
[DT‐02–02]: IDALOPIRDINE, A 5‐HT6 ANTAGONIST, AS ADJUNCTIVE THERAPY TO ACETYLCHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD‐MODERATE ALZHEIMER's DISEASE: KEY OUTCOMES FROM THE STAR PHASE III PROGRAM. (1st July 2017)
Record Type:
Journal Article
Title:
[DT‐02–02]: IDALOPIRDINE, A 5‐HT6 ANTAGONIST, AS ADJUNCTIVE THERAPY TO ACETYLCHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD‐MODERATE ALZHEIMER's DISEASE: KEY OUTCOMES FROM THE STAR PHASE III PROGRAM. (1st July 2017)
Main Title:
[DT‐02–02]: IDALOPIRDINE, A 5‐HT6 ANTAGONIST, AS ADJUNCTIVE THERAPY TO ACETYLCHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD‐MODERATE ALZHEIMER's DISEASE: KEY OUTCOMES FROM THE STAR PHASE III PROGRAM